William Blair Issues Negative Estimate for BMY Earnings
Bristol-Myers Squibb (NYSE:BMY – Free Report) – Stock analysts at William Blair lowered their Q2 2025 earnings per share (EPS) estimates for Bristol-Myers Squibb in a research note issued to investors on Friday, April 25th. William Blair analyst M. Phipps now anticipates that the biopharmaceutical company will post earnings per share of $1.52 for the […]
Bristol-Myers Squibb (NYSE:BMY – Free Report) – Stock analysts at William Blair lowered their Q2 2025 earnings per share (EPS) estimates for Bristol-Myers Squibb in a research note issued to investors on Friday, April 25th. William Blair analyst M. Phipps now anticipates that the biopharmaceutical company will post earnings per share of $1.52 for the […]
